Back to results
US 2026/0234667 A1Published application
Nucleic Acids Encoding TGF-Beta Inhibitor and IL-12 and Uses Thereof
AssigneeKaliVir Immunotherapeutics, Inc.
InventorsStephen Howard THORNE, Mingrui ZHANG
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for a nucleic acids encoding for a transforming growth factor inhibitor and IL-12. Further provided herein are nucleic acids encoding for chemokine receptor CXCR3. Additionally described herein are oncolytic viruses comprising the nucleic acids described herein. Compositions described herein are further described for use in the treatment of cancer.
Claims27
A composition, wherein the composition comprises:
- a vector, wherein the vector comprises:
- an exogenous nucleic acid comprising a sequence encoding for a cytokine or a functional variant thereof;
- an exogenous nucleic acid comprising a sequence encoding for a chemokine receptor or a functional variant thereof;
- and
- a first promoter region, wherein the first promoter region is upstream to the sequence encoding for the chemokine receptor and provides for expression of the chemokine receptor prior to expression of the cytokine.
2 more elements
A nucleic acid molecule, wherein the nucleic acid molecule comprises:
- an insertion at an A52R locus comprising a sequence as set forth in SEQ ID NO:
- 88;
- an insertion at a TK gene locus comprising a sequence as set forth in SEQ ID NO:
- 85.
1 more element
Dependencies are inferred from the claim text.